Concepedia

Saskia C. van der Boor

SC

3

Publications

133

Citations

3

H-Index

2020

Active since

Affiliations

Program for Appropriate Technology in Health(Current)

Imperial College London

Radboud University Nijmegen

Radboud University Medical Center

Radboud Institute for Molecular Life Sciences

Saskia C. van der Boor is an author at Program for Appropriate Technology in Health.

Publications per year

2020–2023

3

Publications

3

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

Meta Roestenberg, Jona Walk, Saskia C. van der Boor et al. · Science Translational Medicine · 2020 · 81 citations · Full text

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

Saskia C. van der Boor, Merel Smit, Stijn W. van Beek et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

Modeling the Impact of a Highly Potent <i>Plasmodium falciparum</i> Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission

Joseph D. Challenger, Stijn W. van Beek, Rob ter Heine et al. · The Journal of Infectious Diseases · 2023 · 11 citations · Full text

Rows per page

1–3 of 3